2016-09-21



Regenerative Medicine Market

Regenerative medicines hold the ability treplace, repair, and regenerate tissues and organs that are affected due tsome disease, injury, or natural ageing process. These medicines are capable of restoring the functionality of tissues & cells applicable in a wide range of degenerative disorders such as neurodegenerative diseases, dermatology, cardiovascular and orthopedic applications. Researchers have been focusing on the development of advanced technologies based on genes, biologics, somatic cells and stem cells. Stem cells have the capability tproliferate and differentiate owing twhich they are of importance in this field. Currently, predominant treatments available for degenerative or life-threatening diseases dnot provide a treatment or are palliative; however, regenerative medicines have the ability treplace or regenerate the tissues and organs suffering from injury or disease. Moreover, the exploitation of nano-materials in drug delivery, wound care and immunomodulation are opportunistic for the regenerative medicine market.

Based on material, the market is classified intsynthetic materials, biologically derived materials, genetically engineered materials, and pharmaceuticals. The world regenerative medicine market is expected treach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022. These materials are further subcategorized intdifferent segments. The biologically derived materials accounted for about 4/7th of total market share in 2015, and is estimated tretain its position during the analysis period. The increasing demand for genetically engineered materials specially due ttheir unique properties such as promotion of increased proliferation, cellular interactions, and differentiation of cells that facilitates self-assembly intorganized structures, and controlling the manipulation of cellular behavior.

Get Free Sample Report of Regenerative Medicine Market @ http://www.intenseresearch.com/market-analysis/regenerative-medicine-market-by-technology-cell-therapy-gene.html#request-sample

The growth of this market is attributed by the factors such as an emergence of stem cell technology, valuable potential of nanotechnology, rising prevalence of chronic diseases & trauma emergencies, innovation in monitoring devices and surgical technologies. Moreover, rising incidence of degenerative diseases specifically and shortage for organ transplants has boosted the market growth. Furthermore, the increasing focus on stem cells with new source, and getting core competency in the emerging economies are expected tsupplement the growth in future. The developing nations are adopting technological advanced treatment modalities at a rapid pace, which is expected tassist in the market expansion worldwide. However, operational inefficiency, stringent regulations, and the high cost of the treatment through regenerative medicine deters the market progression.

The report segments the world regenerative medicine market based on product type, material, application, and geography. Based on product type, it is categorized intcell therapy, gene therapy, tissue engineering, and small molecules & biologics. Cell therapy dominated the market among all other products owing tits efficiency trestore the lost function of any tissue or organ. However, the small molecules & biologics segment is anticipated tgrow at a highest CAGR of 34.2% from 2016 t2022, due tits potential tstimulate dormant or endogenous cells tregain their regenerative properties.

Have Any Query? Ask Our Expert @http://www.intenseresearch.com/market-analysis/regenerative-medicine-market-by-technology-cell-therapy-gene.html#inquiry-for-buying

Key Benefits

The report includes an extensive analysis of the factors driving as well as restraining the world regenerative medicine market.

The study provides an in-depth analysis of the market with current trends and future estimations telucidate the imminent investment pockets.

The report provides a quantitative analysis from 2014 t2022 that is expected tenable the stakeholders tcapitalize on prevailing market opportunities.

Extensive analysis by product, material, application, and geography helps in understanding the various types of devices used for different chronic abnormalities.

Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Key Market Segments:

BY TECHNOLOGY

Cell Therapy

Gene Therapy

Tissue Engineering

Small Molecules & Biologics

BY MATERIAL

Synthetic Materials

Biodegradable Synthetic Polymers

Scaffold

Artificial Vascular Graft Materials

Hydrogel Material

Biologically Derived Materials

Collagen

Xenogeneic Material

Genetically Engineered Materials

Deoxyribonucleic Acid Transfection Vectors

Genetically Manipulated Cells

Three-Dimensional Polymer Technology

Transgenic

Fibroblasts

Neural Stem Cells

Gene-Activated Matrices

Pharmaceuticals

Small Molecules

Biologics

BY APPLICATION

Cardiovascular

Oncology

Dermatology

Musculoskeletal

Wound Healing

Ophthalmology

Neurology

Others

BY GEOGRAPHY

North America

U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Russia

Rest of Europe

Asia-Pacific

Japan

China

India

Australia

South Korea

Taiwan

Rest of Asia-Pacific

LAMEA

Brazil

Turkey

Venezuela

Saudi Arabia

Republic of South Africa

Rest of LAME

About Intense Research

Intense Research provides a range of marketing and business research solutions designed for our client’s specific needs based on our expert resources. The business scopes of Intense Research cover more than 30 industries includsing energy, new materials, transportation, daily consumer goods, chemicals, etc. We provide our clients with one-stop solution for all the research requirements.

Contact Us:

Joel John

3422 SW 15 Street, Suit #8138,

Deerfield Beach, Florida 33442,

United States

Tel: +1-386-310-3803

GMT Tel: +49-322 210 92714

USA/Canada Toll Free No. 1-855-465-4651
Email: sales@intenseresearch.com
Web: http://www.intenseresearch.com/

The post Global Regenerative Medicine Market is expected treach $30,237 million by 2022 at a CAGR of 33.1% during 2016-2022 appeared first on QWTJ Live.

Show more